|
[1]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure[J].Inter J Epidemiol Infect Dis, 2006, 33 (4) :217-221. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].国际流行病学传染病学杂志, 2006, 33 (4) :217-221.
|
|
[2] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for diagnosis and treatment liver failure[J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.
|
|
[3]SARIN SK, KUMAR A, ALMEIDA JA, et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) [J].Hepatol Int, 2009, 3 (1) :269-282.
|
|
[4]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) [J].Hepatol Int, 2014, 8 (4) :453-471.
|
|
[5]OLSON JC, WENDON JA, KRAMER DJ, et al.Intensive care of the patient with cirrhosis[J].Hepatology, 2011, 54 (5) :1864-1872.
|
|
[6]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.
|
|
[7]JALAN R, YURDAYDIN C, BAJAJ JS, et al.Toward an improved definition of acute-on-chronic liver failure[J].Gastroenterology, 2014, 147 (1) :4-10.
|
|
[8]WU T, LI J, SHAO L, et al.Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-onchronic liver failure[J].Gut, 2017.[Epub ahead of print]
|
|
[9]BAJAJ JS, O'LEARY JG, REDDY KR, et al.Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J].Hepatology, 2014, 60 (1) :250-256.
|
|
[10]JANAN R, SALIBA F, PAVESI M, et al.Development and validation of a prognositic score to predict mortality in patients with acute-on-chronic liver failure[J].J Hepatol, 2014, 61 (5) :1038-1047.
|
|
[11]CHOUDHURY A, JINDAL A, MAIWALL R, et al.Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF) :comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models[J].Hepatol Int, 2017, 11 (5) :461-471.
|
|
[12]LIANG XS, LI CZ, ZHOU Y, et al.Changes in circulating Foxp3 (+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure[J].World J Gastroenterol, 2014, 20 (26) :8558-8571.
|
|
[13]GAO MD, ZHAO Y.Research advances in immune factors for the prognosis of patients with acute-on-chronic liver failure[J].J Clin Hepatol, 2017, 33 (12) :2462-2466. (in Chinese) 高梦丹, 赵艳.慢加急性肝衰竭患者预后相关免疫因素研究进展[J].临床肝胆病杂志, 2017, 33 (12) :2462-2466.
|
|
[14]SHI HL, SHI HB, ZHANG R, et al.Expression and implication of the augmenter of liver regeneration protein in acute-on-chronic liver failure[J].Chin J Hepatol, 2014, 22 (1) :63-65. (in Chinese) 时红林, 时红波, 张瑞, 等.肝再生增强因子在慢加急性肝衰竭患者中的表达及其临床意义[J].中华肝脏病杂志, 2014, 22 (1) :63-65.
|
|
[15]ELFIMOVA N, SCHLATTJAN M, SOWA JP, et al.Circulating microRNAs:promising candidates serving as novel biomarkers of acute hepatitis[J].Front Physiol, 2012, 3:476.
|
|
[16]NG R, SONG G, ROLL GR, et al.A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration[J].J Clin Invest, 2012, 122 (3) :1097-1108.
|
|
[17]YUAN Q, LOYA K, RANI B, et al.MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration[J].Hepatology, 2013, 57 (1) :299-310.
|
|
[18]YU ZY, BAI YN, LUO LX, et al.Expression of microRNA-150targeting vascular endothelial growth factor-A is downregulated under hypoxia during liver regeneration[J].Mol Med Rep, 2013, 8 (1) :287-293.
|
|
[19]HAN T, LIU Y, LIU H, et al.Serum thymosinβ4 levels in patients with hepatitis B virus related liver failure[J].World J Gastroenterol, 2010, 16 (5) :625-630.
|
|
[20]REN F, CHEN Y, WANG Y, et al.Comparative serum proteomic analysis of patients with acute-on-chronic liver failure:alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection[J].J Viral Hepat, 2010, 17 (11) :816-824.
|
|
[21]NIE CY, HAN T, ZHANG L, et al.Cross-sectional and dynamic change of serum metabolite profiling for hepatitis B-related acuteon-chronic liver failure by UPLC/MS[J].J Viral Hepat, 2014, 21 (1) :53-63.
|
|
[22]CAI J, ZHANG M, HAN T, et al.Characteristics of infection and its impact on short-term outcome in patients with acute-onchronic liver failure[J].Medicine, 2017, 96 (37) :e8057.
|
|
[23]FERNANDEZ J, ACEVEDO J, WEIST R, et al.Bacterial and fungal infections in acute-on-chronic liver failure:prevalence, characteristics and impact on prognosis[J].Gut, 2017.[Epub ahead of print]
|
|
[24]PLAUTH M, CABRE E, CAMPILLO B, et al.ESPEN Guidelines on Parenteral Nutrition:hepatology[J].Clin Nutr, 2009, 28 (4) :436-444.
|
|
[25]ASPEN Board of Directors and the Clinical Guidelines Task Force.Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients[J].JPEN J Parenter Enteral Nutr, 2002, 26 (1Suppl) :1SA-138SA.
|
|
[26]PLAUTH M, CABRE E, RIGGIO O, et al.ESPEN guidelines on eternal nutrition:liver disease[J].Clin Nutr, 2006, 25 (2) :285-294.
|
|
[27]YANG HZ, DUAN XZ, LIU XY, et al.Evaluation of the safety of granulocyte colony-stimulating factor subcutaneous injection as treatment for HBV-related acute on chronic liver failure[J].Chin J Hepatol, 2015, 23 (5) :378-380. (in Chinese) 杨昊臻, 段学章, 刘晓燕, 等.皮下注射重组人粒细胞集落刺激因子治疗HBV相关慢加急性肝衰竭的安全性研究[J].中华肝脏病杂志, 2015, 23 (5) :378-380.
|
|
[28]SAHA BK, MAHTAB MA, AKBAR SMF, et al.Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure:increased survival and containment of liver damage[J].Hepatol Int, 2017, 11 (6) :540-546.
|
|
[29]MANDORFER M, BOTA S, SCHWABL P, et al.Nonselectiveβblockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis[J].Gastroenterology, 2014, 146 (7) :1680-1690.
|
|
[30]MOOKERJEE RP, PAVESI M, THOMSEN KL, et al.Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure[J].J Hepatol, 2016, 64 (3) :574-582.
|
|
[31]GEHRKE N, HVELMEYER N, WAISMAN A, et al.Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation[J].J Hepatol, 2018.[Epub ahead of print]
|
|
[32]FISHER JE, MCKENZIE TJ, LILLEGARD JB, et al.Role of kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure[J].J Surg Res, 2013, 180 (1) :147-155.
|
|
[33]BI YZ, FAN Z, CHEN DF, et al.Protective effect of intraperitoneal transplantation of human liver-derived stem cells at different times against concanavalin A-induced acute liver injury in mice[J].Chin J Hepatol, 2017, 25 (3) :205-210. (in Chinese) 毕研贞, 樊增, 陈东风, 等.人肝源性干细胞腹腔移植不同时间对刀豆蛋白A诱导小鼠急性肝损伤保护作用[J].中华肝脏病杂志, 2017, 25 (3) :205-210.
|
|
[34]SHI D, ZHANG J, ZHOU Q, et al.Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs[J].Gut, 2017, 66 (5) :955-964.
|
|
[35]SHI M, ZHANG Z, XU R, et al.Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients[J].Stem Cells Transl Med, 2012, 1 (10) :725-731.
|
|
[36]LIN BL, CHEN JF, QIU WH, et al.Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure:A randomized controlled trial[J].Hepatology, 2017, 66 (1) :209-219.
|
|
[37]LI S, CHEN Y.Coping with shortage of plasma-The new therapeutic pattern of non-bioartificial liver[J].J Clin Hepatol, 2017, 33 (9) :1687-1692. (in Chinese) 李爽, 陈煜.血浆紧缺情况下非生物型人工肝治疗新模式的探讨[J].临床肝胆病杂志, 2017, 33 (9) :1687-1692.
|
DownLoad: